Presented by Anastasia Wise, Ph.D.
Saturday, December 8, 2018, 1:30 pm
Argosy University
1550 Wilson Blvd.
Suite 712
Arlington, VA
Near Rosslyn Metro. Parking garage accessible from N. Pierce Street. There is controlled building access so please arrive on time.
Genomic medicine, utilizing genomic information in clinical care, aims to improve clinical management, prevent complications, and promote health. With many names often used interchangeably, including genomic medicine, precision medicine, and personalized medicine, we’ll discuss what genomic medicine is and the clinical testing that is available today to improve diagnosis and therapy. We’ll explore common misconceptions as well as success stories regarding genomic medicine implementation, particularly disease diagnosis, and conclude with what may be possible in the future.
Dr. Wise is a program director in the Division of Genomic Medicine at the National Human Genome Research Institute (NHGRI). She received her Ph.D. in genetics and genomics from Duke University and joined NHGRI in 2010. At NHGRI she serves as project officer for programs advancing the application of genomics to medical science and clinical care with a focus on perinatal sequencing, undiagnosed and rare disease genomic medicine, and sex chromosome analysis and association methods. She is also a project scientist for the Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT) program, which aims to explore the potential implications, challenges and opportunities associated with the possible use of genomic sequence information in the newborn period. Her other research interests include gene-environment interactions in complex disease, pharmaco/toxicogenomics, and ethical, legal, and social issues related to the use of genetic information.
